razoxane has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, S; Li, D; Mi, Y; Wang, J; Wang, Y; Xue, Y | 1 |
| Anderson, P; Chandra, J; Fulbright, JM; Huh, W | 1 |
| Asselin, BL; Athale, U; Barry, EV; Clavell, LA; Cohen, HJ; Colan, SD; Larsen, E; Lipshultz, SE; Lipsitz, SR; Michon, B; Miller, TL; Moghrabi, A; Neuberg, DS; Orav, EJ; Sallan, SE; Samson, Y; Schorin, MA; Scully, RE; Silverman, LB | 1 |
| McBride, D | 1 |
| Asselin, BL; Athale, UH; Clavell, L; Cohen, HJ; Cole, PD; Kelly, KM; Larsen, EC; Laverdière, C; Lipshultz, SE; Michon, B; Neuberg, DS; Sallan, SE; Schorin, M; Schwartz, CL; Silverman, LB; Stevenson, KE; Vrooman, LM | 1 |
| Asselin, BL; Athale, UH; Clavell, LA; Colan, SD; Dahlberg, SE; Henkel, JM; Laverdière, C; Lipshultz, SE; Lipsitz, SR; Michon, B; Miller, TL; Neuberg, DS; Rifai, N; Sallan, SE; Schorin, MA; Scully, RE; Silverman, LB | 1 |
| Aplenc, R; Fisher, BT; Huang, YS; Li, Y; Seif, AE; Torp, K; Walker, DM | 1 |
| Ostański, M; Sońta-Jakimczyk, D | 2 |
| Asselin, BL; Barr, RD; Clavell, LA; Colan, SD; Dalton, VM; Gelber, RD; Hurwitz, CA; Levy, DE; Lipshultz, SE; Lipsitz, SR; Moghrabi, A; Rifai, N; Sallan, SE; Samson, Y; Schorin, MA; Silverman, LB | 1 |
| Fujisaki, G; Inokuchi, C; Murashige, N | 1 |
| Silber, JH | 1 |
| Lipshultz, SE | 1 |
| Asselin, B; Barr, R; Clavell, L; Cohen, HJ; Dalton, VK; Gelber, RD; Hurwitz, C; Levy, DE; Lipshultz, SE; Moghrabi, A; Neuberg, DS; Sallan, SE; Samson, Y; Schorin, M; Silverman, LB | 1 |
| Bárdi, E; Bobok, I; Kappelmayer, J; Kiss, C; V Oláh, A | 1 |
| Asselin, BL; Athale, UH; Barry, EV; Clavell, LA; Cohen, HJ; Dahlberg, SE; Larsen, EC; Lipshultz, SE; Moghrabi, A; Neuberg, DS; Sallan, SE; Samson, Y; Schorin, MA; Silverman, LB; Vrooman, LM | 1 |
| Andoh, T; Ishida, R; Miki, T; Narita, T; Sato, M; Tanabe, K; Utsumi, KR; Yui, R | 1 |
2 review(s) available for razoxane and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Can anthracycline therapy for pediatric malignancies be less cardiotoxic?
Topics: Adolescent; Adult; Anthracyclines; Child; Delayed-Action Preparations; Disease Progression; Doxorubicin; Drug Administration Schedule; Drug Carriers; Drug Dosage Calculations; Drug-Related Side Effects and Adverse Reactions; Heart; Heart Diseases; Heart Failure; Humans; Iron Chelating Agents; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Razoxane; Risk Factors; Treatment Outcome | 2010 |
Exposure to anthracyclines during childhood causes cardiac injury.
Topics: Adolescent; Adult; Anthracyclines; Antineoplastic Agents; Cardiomyopathies; Cardiovascular Agents; Child; Disease Progression; Heart; Heart Failure; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Risk Factors; Survivors | 2006 |
5 trial(s) available for razoxane and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.
Topics: Adolescent; Antibiotics, Antineoplastic; Biomarkers; Canada; Cardiomyopathies; Cardiovascular Agents; Child; Child, Preschool; Disease-Free Survival; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Male; Myocardial Contraction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Puerto Rico; Razoxane; Risk Assessment; Risk Factors; Survivors; Time Factors; Treatment Outcome; Troponin T; Ultrasonography; United States; Ventricular Function, Left; Young Adult | 2010 |
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.
Topics: Antibiotics, Antineoplastic; Biomarkers; C-Reactive Protein; Cardiomyopathies; Cardiotonic Agents; Child; Child, Preschool; Doxorubicin; Echocardiography; Female; Heart; Humans; Male; Natriuretic Peptide, Brain; Peptide Fragments; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Troponin T; Ventricular Function, Left; Ventricular Remodeling | 2012 |
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
Topics: Antibiotics, Antineoplastic; Cardiomyopathies; Cardiovascular Agents; Chelating Agents; Child; Disease-Free Survival; Doxorubicin; Echocardiography; Female; Heart; Humans; Logistic Models; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Razoxane; Troponin T; Ventricular Function, Left | 2004 |
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia.
Topics: Adolescent; Asparaginase; Cardiotonic Agents; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Treatment Outcome | 2007 |
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Infant; Infant, Newborn; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Survival Rate | 2008 |
10 other study(ies) available for razoxane and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Acute leukemia association with psoriasis: a report on 100 patients from a single center in China.
Topics: Adult; Aged; China; Cohort Studies; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promyelocytic Leukemia Protein; Psoriasis; Radiation-Sensitizing Agents; Razoxane; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Transcription Factors; Tumor Suppressor Proteins; Young Adult | 2010 |
Drug may protect children's hearts from chemotherapy.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiovascular Agents; Child; Doxorubicin; Female; Heart Diseases; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Razoxane; Sex Characteristics | 2010 |
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.
Topics: Adolescent; Antineoplastic Agents; Cardiotonic Agents; Child; Child, Preschool; Female; Humans; Incidence; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Risk; Time Factors | 2011 |
Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cohort Studies; Databases, Factual; Female; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Retrospective Studies; Young Adult | 2013 |
[Echocardiographic assessment of circulation system in patients during and 3-5 years after all therapy in childhood].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Agents; Case-Control Studies; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Echocardiography; Female; Heart Diseases; Humans; Infant; Male; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Taxoids; Time Factors; Ventricular Function, Left; Ventricular Function, Right | 2002 |
Doxorubicin-induced myocardial injury.
Topics: Antibiotics, Antineoplastic; Cardiomyopathies; Cardiovascular Agents; Disease-Free Survival; Doxorubicin; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Remission Induction | 2004 |
Can dexrazoxane reduce myocardial injury in anthracycline-treated children with acute lymphoblastic leukemia?
Topics: Antibiotics, Antineoplastic; Cardiomyopathies; Cardiovascular Agents; Chelating Agents; Child; Clinical Trials as Topic; Disease-Free Survival; Doxorubicin; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Razoxane; Troponin T | 2004 |
Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer.
Topics: Acetylglucosaminidase; Adolescent; Adult; Albuminuria; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Child; Child, Preschool; Creatinine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Idarubicin; Infant; Kidney Diseases; Kidney Tubules, Proximal; Lymphoma, Non-Hodgkin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Retrospective Studies | 2007 |
[Exercise tolerance in patients after acute lymphoblastic leukemia treatment in childhood].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cardiovascular Agents; Case-Control Studies; Child; Electrocardiography; Exercise Test; Exercise Tolerance; Female; Heart; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Time Factors | 2001 |
Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors.
Topics: Cell Cycle; Cell Division; Cell Nucleus; Diketopiperazines; DNA Damage; Humans; Mitosis; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Spindle Apparatus; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1991 |